The CXCR3 ligands CXCL9 and CXCL10 were more frequently expressed in ALCL cases (75% and 44%, respectively) than in cHL cases (40% and 25%, respectively) (Supplementary Table S3) [17,34]. Here, CXCL9 is linked to classic Hodgkin lymphoma.